Robin J. Tyacke

3.0k total citations · 1 hit paper
60 papers, 2.0k citations indexed

About

Robin J. Tyacke is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Robin J. Tyacke has authored 60 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 33 papers in Cellular and Molecular Neuroscience and 14 papers in Organic Chemistry. Recurrent topics in Robin J. Tyacke's work include Receptor Mechanisms and Signaling (20 papers), Neuroscience and Neuropharmacology Research (19 papers) and Neurotransmitter Receptor Influence on Behavior (17 papers). Robin J. Tyacke is often cited by papers focused on Receptor Mechanisms and Signaling (20 papers), Neuroscience and Neuropharmacology Research (19 papers) and Neurotransmitter Receptor Influence on Behavior (17 papers). Robin J. Tyacke collaborates with scholars based in United Kingdom, United States and Denmark. Robin J. Tyacke's co-authors include David Nutt, Alan L. Hudson, Laurence Reed, Tom A. Williams, Amanda Feilding, Robin Carhart‐Harris, Stephen M. Husbands, David Erritzøe, Kevin Murphy and Robert Leech and has published in prestigious journals such as Proceedings of the National Academy of Sciences, NeuroImage and Brain.

In The Last Decade

Robin J. Tyacke

58 papers receiving 2.0k citations

Hit Papers

Neural correlates of the psychedelic state as determined ... 2012 2026 2016 2021 2012 200 400 600

Peers

Robin J. Tyacke
Michael B. Gatch United States
Michael P. Johnson United States
Ede Frecska Hungary
Rudy Schreiber Netherlands
Stevin H. Zorn United States
Robin J. Tyacke
Citations per year, relative to Robin J. Tyacke Robin J. Tyacke (= 1×) peers Danilo De Gregorio

Countries citing papers authored by Robin J. Tyacke

Since Specialization
Citations

This map shows the geographic impact of Robin J. Tyacke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin J. Tyacke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin J. Tyacke more than expected).

Fields of papers citing papers by Robin J. Tyacke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin J. Tyacke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin J. Tyacke. The network helps show where Robin J. Tyacke may publish in the future.

Co-authorship network of co-authors of Robin J. Tyacke

This figure shows the co-authorship network connecting the top 25 collaborators of Robin J. Tyacke. A scholar is included among the top collaborators of Robin J. Tyacke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin J. Tyacke. Robin J. Tyacke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Connor, Sean, Trevor W. Robbins, Robin J. Tyacke, et al.. (2025). Study Protocol for ‘PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity’. Cureus. 17(1). e78171–e78171. 1 indexed citations
2.
Palmer, Emily, William Trender, Robin J. Tyacke, Adam Hampshire, & Anne Lingford‐Hughes. (2021). Impact of COVID-19 restrictions on alcohol consumption behaviours. BJPsych Open. 7(5). e167–e167. 4 indexed citations
3.
Tyacke, Robin J., Jim Myers, Ashwin Venkataraman, et al.. (2018). Evaluation of 11C-BU99008, a PET Ligand for the Imidazoline2 Binding Site in Human Brain. Journal of Nuclear Medicine. 59(10). 1597–1602. 59 indexed citations
4.
Venkataraman, Ashwin, Nicholas Keat, James F. Myers, et al.. (2018). First evaluation of PET-based human biodistribution and radiation dosimetry of 11C-BU99008, a tracer for imaging the imidazoline2 binding site. EJNMMI Research. 8(1). 71–71. 9 indexed citations
5.
Parker, Christine A., Nabeel Nabulsi, Daniel Holden, et al.. (2014). Evaluation of 11C-BU99008, a PET Ligand for the Imidazoline2 Binding Sites in Rhesus Brain. Journal of Nuclear Medicine. 55(5). 838–844. 39 indexed citations
6.
Kealey, Steven, Emma M. Turner, Stephen M. Husbands, et al.. (2012). Imaging Imidazoline-I2Binding Sites in Porcine Brain Using11C-BU99008. Journal of Nuclear Medicine. 54(1). 139–144. 26 indexed citations
7.
Paterson, Louise M., Robin J. Tyacke, David Nutt, & Gitte M. Knudsen. (2010). Measuring Endogenous 5-HT Release by Emission Tomography: Promises and Pitfalls. Journal of Cerebral Blood Flow & Metabolism. 30(10). 1682–1706. 111 indexed citations
8.
Tyacke, Robin J., Anne Lingford‐Hughes, Laurence Reed, & David Nutt. (2010). GABAB Receptors in Addiction and Its Treatment. Advances in pharmacology. 58. 373–396. 71 indexed citations
9.
Sączewski, Franciszek, Robin J. Tyacke, Jarosław Sączewski, et al.. (2006). 2-(4,5-Dihydroimidazol-2-yl)benzimidazoles as highly selective imidazoline I2/adrenergic α2 receptor ligands. Bioorganic & Medicinal Chemistry. 14(19). 6679–6685. 7 indexed citations
10.
Kornicka, Anita, Franciszek Sączewski, Jacek Petrusewicz, et al.. (2005). Synthesis and Biological Activities of Novel 1,2,3,5-Tetrahydroimidazo[2,1-b]quinazoline Derivatives.. Polish Journal of Chemistry. 79(1). 89–100. 1 indexed citations
12.
Glennon, Richard A., et al.. (2004). Binding of β-carbolines at imidazoline I2 receptors: a structure–affinity investigation. Bioorganic & Medicinal Chemistry Letters. 14(4). 999–1002. 38 indexed citations
13.
Tyacke, Robin J., et al.. (2004). Pyrazino[1,2-a]indoles as novel high-affinity and selective imidazoline I2 receptor ligands. Bioorganic & Medicinal Chemistry Letters. 14(4). 1003–1005. 8 indexed citations
14.
Tyacke, Robin J., Emma Robinson, Maggie D. Lalies, et al.. (2004). Estimation of endogenous noradrenaline release in rat brain in vivo using [3H]RX 821002. Synapse. 55(2). 126–132. 6 indexed citations
15.
Sączewski, Franciszek, et al.. (2003). 2-(4,5-Dihydro-1H-imidazol-2-yl)indazole (indazim) derivatives as selective I2 imidazoline receptor ligands. European Journal of Pharmaceutical Sciences. 20(2). 201–208. 29 indexed citations
16.
Glennon, Richard A., et al.. (2003). Binding of an imidazopyridoindole at imidazoline I2 receptors. Bioorganic & Medicinal Chemistry Letters. 14(2). 527–529. 9 indexed citations
17.
Tyacke, Robin J., Emma Robinson, David Nutt, & Alan L. Hudson. (2002). 5-Isothiocyanato-2-benzofuranyl-2-imidazoline (BU99006) an irreversible imidazoline2 binding site ligand: in vitro and in vivo characterisation in rat brain. Neuropharmacology. 43(1). 75–83. 14 indexed citations
18.
Grundt, Peter, Emma Robinson, David Nutt, et al.. (2000). Probes for imidazoline binding sites: synthesis and evaluation of a selective, irreversible I2 ligand. Bioorganic & Medicinal Chemistry Letters. 10(6). 605–607. 13 indexed citations
19.
Hudson, Alan L., et al.. (1999). Endogenous Indoleamines Demonstrate Moderate Affinity for I2 Binding Sites. Annals of the New York Academy of Sciences. 881(1). 212–216. 6 indexed citations
20.
Hudson, Alan L., Emma Robinson, Maggie D. Lalies, et al.. (1999). In vitroandin vivoapproaches to the characterization of the α2‐adrenoceptor. Journal of Autonomic Pharmacology. 19(6). 311–320. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026